Evaluating the efficacy and safety of Himplasia (PC-27) in the medical management of benign hyperplasia
نویسنده
چکیده
BPH is characterized by enlargement of prostatic nodules due to a proliferative process involving both the stromal and epithelial elements of the prostate. As the prostate enlarges, the surrounding tissue offers resistance, causing the prostate to press against the urethra. Over a period of time, the urinary bladder wall becomes thicker, sensitive irritation and the bladder begins to contract even with a small quantity of urine, causing more frequent urination. The other clinical manifestations of BPH include obstructive and irritative urinary tract symptoms and infection, urinary retention and hematuria.
منابع مشابه
Role of herbal drugs in the management of benign prostatic hyperplasia: Clinical trial to evaluate the efficacy and safety of Himplasia
This was a double-blinded placebo-controlled clinical trial, which including 98 patients clinically diagnosed as various degrees of benign prostatic hyperplasia and confirmed by pelvic ultrasonography along with uroflowmetry investigations. Himplasia was administered as 1 tablet, twice daily for 6 months. All the patients were clinically examined every month for 6 months and we repeat ultrasono...
متن کاملEvaluation of Plasma Interleukin-8 Concentration in Patients with Prostate Cancer and Benign Prostate Hyperplasia
Background: Prostate specific antigen (PSA) has been used as a screening test for the early detection of prostate cancer (PC) for many years. Although the introduction of PSA test led to a considerable increase in reported prostate cancer cases, there is still some controversy over the sensitivity and specificity of this marker in distinguishing PC patients from those with benign prostate hyper...
متن کاملClinical evaluation of Himplasia in Benign Prostatic Hyperplasia: An Open Clinical Trial
This was an open clinical trial undertaken in 25 elderly male patients in the age group of 45-90 years diagnosed with Benign Prostatic Hyperplasia (BPH) in the Department of Shalya Shalakya, Sir Sundarlal Hospital, Institute of Medical Sciences, Banaras Hindu University, Varanasi. Himplasia was administered at a dose of 2 tablets, twice daily for a period of 3 months. All the patients were foll...
متن کاملStudy of Correlation between Prostate Specific Antigen and Matrix Metalloproteinase-2 Activity in Benign and Malignant Prostate Hyperplasia
There are emerging data on novel tumor markers such as matrix metalloproteinase-2 (MMP-2 or gelatinase-A), which play a key role in tissue invasion and metastasis. We designed an investigation to assess the usefulness of MMP-2 activity as compared to prostate specific antigen (PSA) in cancer staging process. We have analyzed the circulating form of MMP-2 in serum samples of patients suffering f...
متن کاملThe impact of benign prostatic hyperplasia on bladder volume in radiotherapy of prostate cancer
Background: Benign prostatic hyperplasia (BPH) is a common disease among older men and many patients with prostate cancer (PC) also have BPH. External beam radiation therapy (EBRT) is one of the important treatments for PC, nevertheless, few studies have analyzed the effect of BPH on EBRT. We tried to know the risk of bladder toxicity by analyzing the bladder volume variability in patients with...
متن کامل